NASDAQ:PBLA

Panbela Therapeutics Stock Forecast

etoro logo Buy PBLA
*Your capital is at risk
$0.0050
+0 (+0%)
At Close: Jun 25, 2026
Add PBLA to Watchlist?
Some Reasons Why To Add PBLA:
  • Healthy interest coverage ratio of 161.8x
  • Strong return on equity of 396.0%
  • Highly efficient cash conversion (100% FCF/OCF ratio)

PBLA Performance

FAQ

What is the symbol for Panbela Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Panbela Therapeutics Inc. is PBLA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Panbela Therapeutics Inc. Stock?
Panbela Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Panbela Therapeutics Inc. Stock?
Panbela Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Panbela Therapeutics Inc. Stock.

What's the current price of Panbela Therapeutics Inc. Stock?
As of the end of day on the Jun 25, 2026, the price of an Panbela Therapeutics Inc. (PBLA) share was $0.0050.

What is the 52-week high and low for Panbela Therapeutics Inc. Stock?
The 52-week high for Panbela Therapeutics Inc. Stock is $0.251 and the 52-week low is $0.0002.

What is the market capitalization of Panbela Therapeutics Inc. Stock?
As of the Jun 25, 2026, the market capitalization of Panbela Therapeutics Inc. is 971.

When is the next earnings date for Panbela Therapeutics Inc.?
The upcoming earnings date for Panbela Therapeutics Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT PANBELA THERAPEUTICS INC.
Panbela Therapeutics
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ...
GOLDEN STAR
Ticker Change Signal Date
JLL
$298.94
1.61% Jun 23
CBRE
$133.21
1.03% Jun 23
CAG
$13.43
2.72% Jun 23
TTEK
$28.04
1.43% Jun 23
NESR
$25.07
7.62% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE